序号 |
标题 |
次数 |
作者 |
发布时间 |
65251 |
cas:2055024-54-7 Boc-PEG4-Val-Cit-PAB-OH |
112 |
zyl |
2024-12-19 |
65252 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP(CAS: 2055042-82-3) |
96 |
WYQ |
2024-12-19 |
65253 |
Mal-amido-PEG8-val-gly-PAB-OH(CAS: 2353409-52-4) |
104 |
WYQ |
2024-12-19 |
65254 |
cas:160854-54-6,4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene,ADC定制 |
85 |
wyh |
2024-12-19 |
65255 |
cas:2504147-59-3 MC (C5)-Val-Cit |
121 |
zyl |
2024-12-19 |
65256 |
Boc-PEG4-Val-Ala-PAB,可降解的ADC连接体 |
132 |
WYQ |
2024-12-19 |
65257 |
cas:2058075-34-4,DGN549-C , ADC试剂 |
63 |
kx |
2024-12-19 |
65258 |
CAS: 1639939-40-4,Mal-Val-Ala-PAB-PNP,马来酰亚胺-VAL-ALA-PAB-PNP |
118 |
WYQ |
2024-12-19 |
65259 |
Fmoc-VC-PAB-Duocarmycin SA, ADC试剂 |
91 |
kx |
2024-12-19 |
65260 |
Mal-PEG4-Val-Ala-PAB,可降解的ADC(抗体偶联药物)连接子 |
139 |
WYQ |
2024-12-19 |
65261 |
Mal-PEG1-Val-Cit-OH的介绍 |
118 |
zyl |
2024-12-19 |
65262 |
MC-vc-PAB-Monomethyl dolastatin10, ADC试剂 |
78 |
kx |
2024-12-19 |
65263 |
CAS: 1870916-87-2,Mal-Val-Ala-PAB,马来酰亚胺-缬氨酸-丙氨酸-对氨基苯甲酸 |
84 |
WYQ |
2024-12-19 |
65264 |
cas:2395887-69-9 Mal-PEG2-Val-Cit-PAB-PNP |
79 |
zyl |
2024-12-19 |
65265 |
SuO-Val-Cit-PAB-MMAE, ADC试剂 |
71 |
kx |
2024-12-19 |
65266 |
Mal-PEG4-Val-Ala-PAB-PNP的介绍 |
82 |
zyl |
2024-12-19 |
65267 |
CAS: 2348405-93-4,DBCO-PEG4-Val-Ala-PAB-PNP |
59 |
WYQ |
2024-12-19 |
65268 |
CAS: 2348405-92-3,DBCO-PEG4-Val-Ala-PAB |
71 |
WYQ |
2024-12-19 |
65269 |
cas:2112738-13-1 Mal-amido-PEG2-Val-Cit-PAB-PNP |
72 |
zyl |
2024-12-19 |
65270 |
Azido-PEG4-Val-Ala-PAB,分子式:C29H48N8O9 |
63 |
WYQ |
2024-12-19 |
65271 |
cas:2055896-86-9,MC-Val-Cit-PAB-tubulysin5a , ADC试剂 |
80 |
kx |
2024-12-19 |
65272 |
Azido-PEG8-Val-Cit-PAB-PNP |
57 |
zyl |
2024-12-19 |
65273 |
cas:2055896-83-6,MC-Val-Cit-PAB-carfilzomib , ADC试剂 |
103 |
kx |
2024-12-19 |
65274 |
MAL-di-EG-Val-Cit-PAB-MMAF, ADC试剂 |
71 |
kx |
2024-12-19 |
65275 |
cas:2353409-45-5 endo BCN-PEG3-VC-PFP Ester |
79 |
zyl |
2024-12-19 |
65276 |
Hydrazone-doxorubicin, ADC试剂 |
141 |
kx |
2024-12-19 |
65277 |
DBCO-C4-Val-Cit-PABC-PNP |
59 |
zyl |
2024-12-19 |
65278 |
cas:644981-35-1 Val-Cit-PAB-MMAE |
69 |
zyl |
2024-12-19 |
65279 |
cas:170908-81-3,DOTA-NHS ester ,1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
62 |
kx |
2024-12-19 |
65280 |
endo-BCN-PEG4-Val-Cit-PAB-MMAE的介绍 |
72 |
zyl |
2024-12-19 |
65281 |
cas:2259318-50-6,MA-PEG4-VA-PBD , ADC试剂 |
85 |
kx |
2024-12-19 |
65282 |
CAS: 2259318-55-1 - DBCO-(PEG2-VC-PAB-MMAE)2 |
57 |
WYQ |
2024-12-19 |
65283 |
CAS: 2768446-73-5,DBCO-Val-Cit-PAB-MMAE |
69 |
WYQ |
2024-12-19 |
65284 |
MC-vc-PAB-C6-a-amanitin, ADC试剂 |
59 |
kx |
2024-12-19 |
65285 |
cas:663598-98-9,2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate,ADC定制 |
75 |
wyh |
2024-12-19 |
65286 |
cas:2873452-49-2 MC-EVCit-PAB-MMAE |
77 |
zyl |
2024-12-19 |
65287 |
2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate,ADC定制 |
86 |
wyh |
2024-12-19 |
65288 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin |
108 |
zyl |
2024-12-19 |
65289 |
Gly3-vc-PAB-MMAE, ADC试剂 |
86 |
kx |
2024-12-19 |
65290 |
CAS: 1869126-64-6, Azido-PEG4-Val-Cit-PAB-MMAE |
68 |
WYQ |
2024-12-19 |
65291 |
cas:2353409-54-6 , Mal-amido-PEG8-Val-Gly,ADC定制 |
81 |
wyh |
2024-12-19 |
65292 |
Azido-PEG4-Val-Ala-PAB-PNP |
84 |
zyl |
2024-12-19 |
65293 |
NOTA-(NGR)2 NOTA偶联NGR二聚体 |
71 |
h |
2024-12-19 |
65294 |
1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid,ADC定制 |
82 |
wyh |
2024-12-19 |
65295 |
CAS: 1343476-44-7,Val-Ala-PAB-OH |
68 |
WYQ |
2024-12-19 |